Analyst Whitney Ijem from Canaccord Genuity maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) and increased the ...

RCKT incurs narrower-than-expected third-quarter 2024 loss. The company provides updates on its pipeline candidates.

Rocket Pharmaceuticals is also progressing in its other projects, like the rolling BLA for Fanconi anemia and the Phase 1 enrollment completion in PKP2-arrhythmogenic cardiomyopathy. Furthermore, the ...

RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

Ulcerative colitis (UC) is a chronic gut inflammatory condition affecting the colon in humans. This study uses human samples as well as a mouse model of colitis induced by a chemical, DSS, to ...

Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that ...

通过详细的病史询问、体格检查、实验室及放射学检查，可初步做出低磷血症或低磷性佝偻病的诊断。任何佝偻病，包括营养性佝偻病、维生素D代谢异常所导致的佝偻病以及低磷性佝偻病，病理生理基础都是低磷血症。低磷性佝偻病会出现类似维生素D和（或）钙缺乏所导致的佝偻 ...

To steer their companies successfully through 2025, CEOs must confront a pivotal truth: the path ahead is increasingly ...

我们经常在生活中和社交平台上经常见到白血病患儿，而且很大一部分是儿童患有白血病，不少家长疑惑为什么孩子会患有白血病呢？下面听听专家关于孩子患有白血病的原因介绍，一起来了解吧。 为什么孩子会患有白血病 病毒 ...

Mirae Asset Global Investments Co. Ltd. raised its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 21.5% during the third quarter, according to its most recent filing with the ...

Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools ...